Reata Pharmaceuticals: Biogen's $7.3 Billion Acquisition of Reata Pharmaceuticals
Cravath acted as legal advisor to Biogen, Vinson & Elkins acted as legal advisor to Reata, and Skadden advised Goldman Sachs. Biogen Inc. (Nasdaq: BIIB) and [...]
Read full article »
Reata Pharmaceuticals is a Texas-based pharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cellular disorders and inflammation.
Read more